Close Menu

NEW YORK (GenomeWeb) – Abbott said Wednesday that its fourth quarter diagnostic revenues grew 3 percent year over year on a reported basis and 7 percent on an organic basis to $1.96 billion from $1.91 billion in the year-ago period.

For the three months ended Dec. 31, 2018, Abbott reported worldwide revenues of $7.77 billion, up 2 percent from $7.59 billion a year ago, but lower than the average Wall Street estimate of $7.82 billion. Sales increased 6 percent year over year on an organic basis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.